Rajiv Malik

Non-Executive Non-Independent and
Nominee Director of Mylan Inc. (Viatris)

Member of Board of Directors since 2022
Nationality: U.S.

Professional Experience

• Over 36 years of experience in the pharmaceutical industry
• Serves on the Viatris Board of Directors
• Served as President of Viatris from November 2020 until his retirement in April 2024
• Served as President and Director of Mylan, where he led the company’s global commercial, scientific, operational, and business development activities
• Played a key role in integrating Mylan and Upjohn, formerly a division of Pfizer, to form Viatris
• He has previously served as
  • Chief Executive Officer of Matrix Laboratories Limited (now Mylan Laboratories Limited)
  • Head of Global Development and Registrations for Sandoz GmbH
  • Head of Global Regulatory Affairs and Head of Pharma Research for Ranbaxy

Education

• Master’s degree in pharmaceutical technology from Punjab University, India